Psoriatic Arthritis Market Sees Major Shift with Growing Biosimilar Adoption | DelveInsight
Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...
Medscape3d
Metabolic Syndrome and Radiographic Damage in Psoriatic Arthritis: Is There a Link?
Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...
Rheumatology Advisor20h
Inflammatory Arthropathy Risk Increased in Patients With Hidradenitis Suppurativa
Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.
Medscape2d
Deucravacitinib Meets Endpoints in Phase 3 PsA Trial
Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...
DelveInsight Business Research, LLP: Psoriatic Arthritis Market Sees Major Shift with Growing Biosimilar Adoption | DelveInsight
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...